Normal view MARC view ISBD view

Resilient ageing: a concept analysis. [electronic resource]

By:

Hicks, Maxine M

Contributor(s):

Conner, Norma E

Producer: 20141114Description: 744-55 p. digitalISSN:

1365-2648

Subject(s):

Online resources:

Available from publisher's website

In: Journal of advanced nursing vol. 70

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

12601 UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma.
by Li, Xiaoxi
12602 Outcome of relapsed or refractory acute myeloid leukemia treated with intensive salvage chemotherapy in real life in comparison to intermediate dose cytarabine in phase 3 studies.
by Bertoli, Sarah
12603 Significance of Granulocyte Colony-Stimulating Factor-Combined High-Dose Cytarabine, Cyclophosphamide, and Total Body Irradiation in Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignant Neoplasms.
by Nakamura, Y
12604 Unexpected beta adrenergic effects of the antitumor agent, cyclocytidine, on rat salivary glands.
by Schneyer, C A
12605 [Long-term treatment and prognostic factors in adult acute myeloblastic leukemia. Experience of the INNSZ group Puebla-Monterrey-Mexico)].
by Lobato-Mendizabal, E
12606 Treatment of acute nonlymphocytic leukemia by combination of recombinant human granulocyte colony-stimulating factor and cytotoxic agents: a report of six cases.
by Hanazono, Y
12607 Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
by Crist, W
12608 Phenotypic analysis of 1-B-D-arabinofuranosylcytosine deamination in patients treated with high doses and correlation with response.
by Kreis, W
12609 ProMACE-cytaBOM versus MACOP-B in intermediate and high grade NHL. Preliminary results of a prospective randomized trial.
by Federico, M
12610 Effect of second-messenger modulators in K-562 cell differentiation: dual action of calcium/phospholipid-dependent protein kinase in the process of differentiation.
by Yumoto, Y
12611 Pharmacology of 3,5-diamino-1,24-triazole (guanazole). 1. Antitumor activity of guanazole.
by Hahn, M A
12612 Experimental studies with L-asparaginase in mouse leukemias.
by Burchenal, J H
12613 Contributions of host- and disease-related attributes to the outcome of patients with acute myelogenous leukemia.
by Curtis, J E
12614 High-dose cytarabine in consolidation chemotherapy or with bone marrow transplantation for patients with acute leukemia: preliminary results.
by Champlin, R
12615 Characteristics of a conditional mutant of Rous sarcoma virus defective in ability to transform cells at high temperature.
by Biquard, J M
12616 Combination treatment of intraocular lymphoma.
by Valluri, S
12617 Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia.
by Takahashi, S
12618 Effects of antisense p21 (WAF1/CIP1/MDA6) expression on the induction of differentiation and drug-mediated apoptosis in human myeloid leukemia cells (HL-60).
by Freemerman, A J
12619 All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group.
by Kanamaru, A
12620 High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease.
by Weaver, C H